Arbutus Biopharma Corp (ABUS): Cash & Equivalents
$18.01M
As of 2025-12-31
$19.17M
As of 2026-06-30
-16.4%
3-year compound annual growth
-19.2%
5-year compound annual growth
-20.0%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $18.01M | -50.4% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $36.33M | +38.2% | 2026-03-23, Balance as of period end |
| 2023-12-31 | $26.29M | -14.6% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $30.78M | -71.8% | 2024-03-05, Balance as of period end |
| 2021-12-31 | $109.28M | +109.1% | 2023-03-02, Balance as of period end |
| 2020-12-31 | $52.25M | +64.3% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $31.80M | -13.9% | 2021-03-04, Balance as of period end |
| 2018-12-31 | $36.94M | -32.0% | 2020-03-05, Balance as of period end |
| 2017-12-31 | $54.29M | +131.9% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $23.41M | -86.0% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $166.78M | +131.0% | 2018-03-16, Balance as of period end |
| 2014-12-31 | $72.19M | +5.0% | 2017-03-22, Balance as of period end |
| 2013-12-31 | $68.72M | +46.1% | 2016-03-09, Balance as of period end |
| 2012-12-31 | $47.02M | +420.7% | 2015-03-13, Balance as of period end |
| 2011-12-31 | $9.03M | n/a | 2014-03-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | $18.01M | -50.4% |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | $45.09M | +48.7% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $15.42M | -20.8% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $207.64M | +110.2% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $44.06M | +171.1% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $2.13M | +53.1% |
| uniQure N.V. (QURE) | 2025-12-31 | $80.24M | -49.5% |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $35.26M | +182.6% |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | $968.0K | -87.9% |
Compare ABUS, IRD, PYXS, TNXP side by side · Screen every company in Pharmaceutical Preparations ↗